Mettler-Toledo International price to free cash flow MTD
Market value divided by free cash flow over the last twelve months, since 2011.
- Today, Oct 23, 2026
- 38.7×
- 10-year median
- 37.9×
- Against its 10-year history
- 55th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 24.3× to 53.0×
- Peer median
- 29.9×
Mettler-Toledo International's price to free cash flow is 38.7× as of Oct 23, 2026.
That is above its ten-year median of 37.9×, close to the middle of its last ten years.
Over that time it ranged from 24.3× in Apr 2025 to 53.0× in Feb 2023.
The median for 10 diagnostics and research stocks of a similar size is 29.9×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 38.7× | 26.3× | 38.7× |
| 2025 | 32.6× | 24.3× | 34.8× |
| 2024 | 29.7× | 28.2× | 36.0× |
| 2023 | 30.2× | 25.0× | 53.0× |
| 2022 | 48.1× | 33.7× | 49.5× |
| 2021 | 47.9× | 39.3× | 49.7× |
| 2020 | 45.8× | 30.0× | 47.5× |
| 2019 | 40.0× | 33.6× | 47.2× |
| 2018 | 35.5× | 34.7× | 51.2× |
| 2017 | 45.9× | 31.1× | 49.3× |
| 2016 | 31.4× | 24.1× | 32.8× |
| 2015 | 26.8× | 22.7× | 28.9× |
| 2014 | 29.0× | 23.2× | 29.0× |
| 2013 | 27.8× | 25.9× | 31.1× |
| 2012 | 26.2× | 24.2× | 41.2× |
| 2011 | 33.1× | 28.3× | 37.4× |
Against its peers
Companies in Medical - Diagnostics & Research nearest Mettler-Toledo International's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| MTDMettler-Toledo International | 38.7× |
| ILMNIllumina | 43.7× |
| DGXQuest Diagnostics | 19.8× |
| LHLabcorp | 23.1× |
| IDXXIDEXX Laboratories | 35.2× |
| WATWaters | 112× |
| IQVIQVIA | 21.1× |
| AAgilent Technologies | 38.5× |
| MEDPMedpace | 26.4× |
| RVTYRevvity | 31.7× |
| BIOBio-Rad Laboratories | 28.0× |
| Peer median | 29.9× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Mettler-Toledo International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.